Search results for "Prostate cancer"
Warnings added to prostate cancer drugs
Talk about health care reform with CMS Administrator Don BerwickPQRI incentive payments now being sentAre you enrolled in PECOS?
https://immattersacp.org/weekly/archives/2010/10/26/7.htm
26 Oct 2010
Guidelines suggest more informed consent for prostate cancer screening
MKSAP Quiz: optimal management of coronary artery disease
https://immattersacp.org/weekly/archives/2010/03/09/2.htm
9 Mar 2010
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013
New guidance urges caution on testosterone
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020
Prostate cancer treatment options result in similar 15-year outcomes
Functional outcomes among men undergoing prostatectomy or radiotherapy for prostate cancer differed at two and five years of follow-up, but significant differences were no longer present by 15 years, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/4.htm
5 Feb 2013
Internists should follow up with prostate cancer patients receiving ADT
Some H1N1 vaccine to expire next week Didanosine gets labeling change Hemodialysis system recalled
https://immattersacp.org/weekly/archives/2010/02/09/5.htm
9 Feb 2010
Model predicts erectile function after prostate cancer
Researchers have developed a new model to predict the risk of erectile dysfunction for men undergoing prostate cancer treatment.
https://immattersacp.org/weekly/archives/2011/09/27/4.htm
27 Sep 2011
High-value management of patients with GI symptoms
Gastroesophageal reflux disease, rectal bleeding, and chronic diarrhea can be controlled better by applying high-value care.
https://immattersacp.org/archives/2017/06/gastro.htm
1 Jun 2017
No mortality benefit associated with primary androgen deprivation therapy in localized prostate cancer
Primary androgen deprivation therapy (PADT) yielded no mortality benefit compared with no PADT in men with clinically localized prostate cancer, according to a new study.
https://immattersacp.org/weekly/archives/2014/03/25/5.htm
25 Mar 2014
European study finds prostate cancer mortality reduced by PSA screening
Prostate-specific antigen (PSA)-based screening significantly reduced mortality from prostate cancer but did not affect all-cause mortality, according to two more years of follow-up results in the European Randomized Study of Screening for Prostate Cancer.
https://immattersacp.org/weekly/archives/2012/03/20/4.htm
20 Mar 2012